These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20040773)

  • 1. Correlation between substantia nigra features detected by sonography and Parkinson disease symptoms.
    Bártová P; Skoloudík D; Ressner P; Langová K; Herzig R; Kanovsky P
    J Ultrasound Med; 2010 Jan; 29(1):37-42. PubMed ID: 20040773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).
    Prati P; Bignamini A; Coppo L; Naldi A; Comi C; Cantello R; Gusmaroli G; Walter U
    J Neural Transm (Vienna); 2017 Jul; 124(7):869-879. PubMed ID: 28451942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
    Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
    Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease.
    Fan Y; Ma J; Yang D; Li X; Liang K; She Z; Qi X; Shi X; Gu Q; Zheng J; Li D
    Eur J Neurosci; 2024 May; 59(10):2702-2714. PubMed ID: 38469656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
    Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
    Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new program for highly reproducible automatic evaluation of the substantia nigra from transcranial sonographic images.
    Blahuta J; Soukup T; Jelinkova M; Bartova P; Cermak P; Herzig R; Skoloudik D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec; 158(4):621-7. PubMed ID: 23640029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
    Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
    J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperechogenicity of the substantia nigra in Parkinson's disease.
    Ressner P; Skoloudík D; Hlustík P; Kanovský P
    J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
    Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
    Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcranial sonography in the evaluation of Parkinson disease.
    Kolevski G; Petrov I; Petrova V
    J Ultrasound Med; 2007 Apr; 26(4):509-12. PubMed ID: 17384048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism.
    Oh YS; Kwon DY; Kim JS; Park MH; Berg D
    Parkinsonism Relat Disord; 2018 Jan; 46():36-40. PubMed ID: 29111425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease.
    van de Loo S; Walter U; Behnke S; Hagenah J; Lorenz M; Sitzer M; Hilker R; Berg D
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1087-92. PubMed ID: 20543186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonography for diagnosis of Parkinson disease-from theory to practice: a study on 300 participants.
    Alonso-Cánovas A; López-Sendón JL; Buisán J; deFelipe-Mimbrera A; Guillán M; García-Barragán N; Corral I; Matute-Lozano MC; Masjuan J; Martínez-Castrillo JC; Walter U
    J Ultrasound Med; 2014 Dec; 33(12):2069-74. PubMed ID: 25425362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
    Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
    J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of substantia nigra echogenicity and motor function in elderly subjects.
    Berg D; Siefker C; Ruprecht-Dörfler P; Becker G
    Neurology; 2001 Jan; 56(1):13-7. PubMed ID: 11148229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.
    Li T; Shi J; Qin B; Fan D; Liu N; Ni J; Zhang T; Zhou H; Xu X; Wei M; Zhang X; Wang X; Liu J; Wang Y; Tian J
    Neurol Sci; 2020 Mar; 41(3):661-667. PubMed ID: 31754876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transcranial sonography of substantia nigra in patients with Parkinson's disease].
    Miwa H
    Rinsho Shinkeigaku; 2013; 53(11):981-2. PubMed ID: 24291852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transcranial sonography for the diagnosis of Parkinson disease].
    Venegas F P; Miranda G G; Silva C MC
    Rev Med Chil; 2011 Jan; 139(1):54-9. PubMed ID: 21526317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.